Alert issued over one batch of Calcichew-D3 500mg/400 IU Caplets

Alert issued over one batch of Calcichew-D3 500mg/400 IU Caplets

November 30 2017 A drug alert has been issued for a batch of Calcichew-D3 500mg/400 IU Caplets...

Viagra Connect to be available as an OTC medicine

Viagra Connect to be available as an OTC medicine

November 29 2017 Pfizer has announced that it will launch Viagra Connect as a Pharmacy (P)...

Self Care Week picks up publics frustrations around GP appointments

Self Care Week picks up publics frustrations around GP appointments

November 14 2017 One in ten people says they are driven to exaggerate symptoms in order to get a...

Vaping should be ‘promoted’ as smoking cessation aid

Vaping should be ‘promoted’ as smoking cessation aid

October 17 2017 Electronic cigarettes should be promoted as a method of stopping smoking, the...

MHRA issues Drug Safety Updates for loperamide and miconazole

MHRA issues Drug Safety Updates for loperamide and miconazole

October 4 2017 The medicines regulator, the MHRA, has issued Drug Safety Updates on two...

  • Alert issued over one batch of Calcichew-D3 500mg/400 IU Caplets

    Alert issued over one batch of Calcichew-D3 500mg/400 IU Caplets

    Thursday, 30 November 2017 09:26
  • Viagra Connect to be available as an OTC medicine

    Viagra Connect to be available as an OTC medicine

    Wednesday, 29 November 2017 12:46
  • Self Care Week picks up publics frustrations around GP appointments

    Self Care Week picks up publics frustrations around GP appointments

    Tuesday, 14 November 2017 18:58
  • Vaping should be ‘promoted’ as smoking cessation aid

    Vaping should be ‘promoted’ as smoking cessation aid

    Tuesday, 17 October 2017 14:31
  • MHRA issues Drug Safety Updates for loperamide and miconazole

    MHRA issues Drug Safety Updates for loperamide and miconazole

    Wednesday, 04 October 2017 16:25

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

A Resized Pharmacy Image cbAugust 29 2017

Which? has published an article questioning the effectiveness of some over the counter medicines, and advising its readers to consider cheaper alternatives to branded items.

Appearing in the September issue, the article “names the widely available medicines and supplements that aren’t all they’re cracked up to be.” It covers 10 brands including cold and flu remedies, analgesics, oral care, ear drops and vitamin and mineral supplements.

It argues that it is not always possible to decide whether OTC products are worth the money, and that there are often “far cheaper alternatives that work just as well.” It also calls on manufacturers to be more open in publishing efficacy evidence. “In the meantime, be sure to ask the pharmacist any questions about the products, and check the key active ingredients to see if you can find a cheaper alternative,” it tells its readers.

Responding to the article, the branded OTC manufacturers’s trade body, the Proprietary Association of Great Britain, said the wide range of branded and generic OTC medicines, ensures people have a choice to suits their needs and their budget.

John Smith, PAGB Chief Executive, commented: “Branded OTC medicines enjoy a long-standing heritage of trust and manufacturers invest heavily in research and product development. In order for a medicine to be granted a licence, manufacturers must provide robust evidence to show it is effective before it can be sold in pharmacies and other retail stores.

“The manufacturers behind the well-known brands are often first to bring medicines to market with benefits such as a faster onset of action, prolonged duration or products that were previously only available on prescription. As Which? points out, some OTC products are marketed to target specific symptoms, this is because having these displayed on the front of the pack helps people choose a suitable product more easily, particularly in a shop where there isn’t a pharmacist to ask.

“Unlike new prescription drugs, which enjoy lengthy patent protection, it is exceedingly rare for new OTC medicines to have any form of protection once launched. Other companies are then free to produce and sell copies or generics at a lower price, because they don’t have to carry out the research and development. It is for these reasons of commercial confidentiality that detailed data on product efficacy is only shared with regulators.

“We support the Which? recommendation to always read the label and if people are still unsure, they should consult a pharmacist. Pharmacists are expert healthcare professionals who can provide information and support to help you to self care.”

Links:
Which?                                 
PAGB comment                  

 

OTC News

January 22 2018 Plans by the main NHS education organisation for England to expand training programmes for community pharmacy have been welcomed by the Royal Pharmaceutical Society.
January 22nd 2018 NHS England will launch a public health campaign promoting community pharmacies to parents with young children next month.